Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its COVID-19 vaccine ZyCoV-D.from Stocks-Markets-Economic Times https://ift.tt/3ooHIst
Stocks in the news: RIL, BEML, RCF, SAIL, Ashok Leyland and Adani Green
Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its COVID-19 vaccine ZyCoV-D.from Stocks-Markets-Economic Times https://ift.tt/3ooHIst
Related Posts:
Inox Wind board Approves Fundraise of Rs 75 cr- Dhanlaxmi Bank shareholders seek to curb CEO spending powers
- ITC Q2 Results: Revenue from operations surged 26.6% to Rs 17,159.56 cr, beats street estimates
- Axis Bank Q2 profit zooms 70% YoY to Rs 5,330 crore
- Central Bank of India Q2 net profit rises 27% to Rs 318 crore
0 Comments:
Post a Comment